CV pharmacotherapy – Which agents cannot be used and why?
Topic:
Pharmacology and Pharmacotherapy
Speaker:
Professor J. Tamargo (Madrid, ES)
Seminar Session
About the speaker
Professor Juan Luis Tamargo
Complutense University of Madrid, Madrid (Spain)
8
presentations
2
followers
Access the full session
About the event
Related content
EHRA Premium Access
Management of channelopathies in the pediatric population.
5 April 2022
EHRA Premium Access
2019 ESC Guidelines for the management of patients with supraventricular tachycardia: did indications for catheter ablation change?
5 April 2022
ACVC Premium Access
The patient with acute myocarditis.
19 March 2022
This platform is supported by
